Bowen Hanes & Co’s Merck MRK Stock Holding History

Bowen Hanes & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$265K	Hold	2,204	–	–	0.01%	139
2025 Q4	$232K	Buy	+2,204	New	+$207K	0.01%	149
2025 Q1	–	Sell	-2,204	Closed	-$219K	–	158
2024 Q4	$219K	Hold	2,204	–	–	0.01%	147
2024 Q3	$250K	Hold	2,204	–	–	0.01%	142
2024 Q2	$273K	Hold	2,204	–	–	0.01%	141
2024 Q1	$291K	Sell	2,204 -86	-4%	-$10.6K	0.01%	142
2023 Q4	$250K	Hold	2,290	–	–	0.01%	142
2023 Q3	$236K	Hold	2,290	–	–	0.01%	139
2023 Q2	$264K	Sell	2,290 -55	-2%	-$6.25K	0.01%	137
2023 Q1	$249K	Hold	2,345	–	–	0.01%	137
2022 Q4	$260K	Hold	2,345	–	–	0.01%	138
2022 Q3	$202K	Sell	2,345 -1,040	-31%	-$92.8K	0.01%	145
2022 Q2	$309K	Buy	3,385 +76	+2%	+$6.74K	0.01%	137
2022 Q1	$272K	Hold	3,309	–	–	0.01%	149
2021 Q4	$254K	Hold	3,309	–	–	0.01%	156
2021 Q3	$249K	Sell	3,309 -40	-1%	-$3.04K	0.01%	149
2021 Q2	$260K	Sell	3,349 -1,198	-26%	-$89.1K	0.01%	142
2021 Q1	$334K	Hold	4,547	–	–	0.01%	134
2020 Q4	$355K	Hold	4,547	–	–	0.01%	131
2020 Q3	$360K	Hold	4,547	–	–	0.01%	122
2020 Q2	$336K	Sell	4,547 -11	-0.2%	-$828	0.01%	124
2020 Q1	$335K	Hold	4,558	–	–	0.02%	123
2019 Q4	$396K	Hold	4,558	–	–	0.02%	127
2019 Q3	$366K	Hold	4,558	–	–	0.02%	128
2019 Q2	$365K	Sell	4,558 -3,144	-41%	-$241K	0.02%	126
2019 Q1	$611K	Sell	7,702 -14,588	-65%	-$1.09M	0.03%	112
2018 Q4	$1.63M	Buy	22,290 +17,732	+389%	+$1.25M	0.08%	95
2018 Q3	$309K	Hold	4,558	–	–	0.01%	126
2018 Q2	$264K	Buy	4,558 +63	+1%	+$3.55K	0.01%	131
2018 Q1	$234K	Hold	4,495	–	–	0.01%	132
2017 Q4	$241K	Hold	4,495	–	–	0.01%	135
2017 Q3	$275K	Hold	4,495	–	–	0.01%	136
2017 Q2	$275K	Hold	4,495	–	–	0.01%	136
2017 Q1	$273K	Hold	4,495	–	–	0.01%	133
2016 Q4	$252K	Sell	4,495 -262	-6%	-$15.3K	0.01%	128
2016 Q3	$283K	Hold	4,757	–	–	0.02%	127
2016 Q2	$261K	Buy	+4,757	New	+$253K	0.01%	125
2016 Q1	–	Sell	-6,876	Closed	-$347K	–	138
2015 Q4	$347K	Hold	6,876	–	–	0.02%	125
2015 Q3	$324K	Buy	6,876 +2,730	+66%	+$145K	0.02%	130
2015 Q2	$225K	Sell	4,146 -105	-2%	-$5.89K	0.01%	144
2015 Q1	$233K	Buy	4,251 +105	+3%	+$5.95K	0.01%	136
2014 Q4	$225K	Buy	+4,146	New	+$231K	0.01%	140

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bowen Hanes & Co's MRK Position: Q1 2026 in Review

Bowen Hanes & Co held its Merck (MRK) position steady in Q1 2026 at 2,204 shares worth $265K. The position accounts for 0.01% of the portfolio, ranked #139.

Bowen Hanes & Co first reported a position in MRK in Q4 2014 and has held it in 42 quarters since. The position peaked at $1.63M in Q4 2018. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Bowen Hanes & Co held 2,204 shares of Merck worth $265K as of Q1 2026.
Bowen Hanes & Co left its Merck share count unchanged in Q1 2026.
Merck made up 0.01% of Bowen Hanes & Co's portfolio in Q1 2026, its #139 holding.
Bowen Hanes & Co first reported a position in Merck in Q4 2014 and has held it in 42 quarters since.
Bowen Hanes & Co's Merck position peaked at $1.63M in Q4 2018.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bowen Hanes & Co's 13F filing for Q1 2026, filed 14 May 2026.